Making diagnostic imaging possible for patients with cardiac implants

March 19, 2014 by Shantell Kirkendoll
Making diagnostic imaging possible for patients with cardiac implants
Dr. Eric D. Good, left, implants ICD at University of Michigan Cardiovascular Center.

The University of Michigan Frankel Cardiovascular Center is on the forefront of making diagnostic imaging possible for patients with cardiac implants.

Electrophysiologist Eric D. Good, D.O., has implanted the state's first patient with BIOTRONIK's Iforia heart device. It's the only implantable cardioverter-defibrillator (ICD) approved for investigational use in (MRI).

The device is commercially available, but is in the newest phase of the ongoing ProMRI trial, a study that will examine ProMRI technology in the MRI environment.

"This technology is intended to allow full diagnostic capabilities for our who are likely to benefit from MRI scans," says Good.  "We are very excited to be participating in the ProMRI trial."

Every year, more than 300,000 people are implanted with ICD systems to regulate their heartbeat, and studies estimate that 50 percent to 75 percent will need an MRI scan in their lifetime.

MRI scans often provide diagnostic capabilities for certain diseases or conditions that cannot be adequately examined by x-ray, computerized tomography (CT) or ultrasound.

The strong magnetic forces applied during MRIs can potentially have a negative effect on both the device and leads, and are usually not recommended for pacemaker and ICD patients.

"MRI is a safe and reliable diagnostic technology, and demand for imaging studies is growing," says Theofanie Mela, M.D., director of Pacer and ICD Clinic at Massachusetts General Hospital in Boston. "ICD patients are frequently recommended for MRI scans, but until now they have been unable to receive them."

The ICD ProMRI with exclusion zone study is designed to confirm the safety and efficacy of BIOTRONIK's Iforia ICD during an MRI scan. All the devices in the study are conditionally approved by the U.S. Food and Drug Administration for use in the study, but still await FDA approval for use in the MRI environment.

Aside from featuring ProMRItechnology, the single chamber Iforia series is one of the smallest ICDs in the world and also offers more than 11 years longevity. This allows for a low replacement rate—a benefit for both patients and the health care system.

The latest phase of the ProMRI clinical study will recruit and evaluate 172 patients at 35 U.S. investigational centers, including the University of Michigan Cardiovascular Center.

The U-M's Heart Rhythm Program focuses on the diagnosis and treatment of all types of arrhythmias, or abnormal heart rhythms, including atrial fibrillation and flutter, sick sinus syndrome, sinus tachycardia, sinus bradycardia, ventricular tachycardia and genetic arrhythmia syndromes such as prolonged QT syndrome.

Explore further: MRI-friendly defibrillator implant opens doors for thousands of cardiac patients currently denied MRIs

Related Stories

Magnetic resonance imaging with side effects

April 30, 2012

Great care should be taken when performing magnetic resonance imaging (MRI) in patients with a cardiac pacemaker. Henning Bovenschulte and his co-authors review recent findings in the latest issue of Deutsches Ärzteblatt ...

New implanted defibrillator works well without touching heart

August 26, 2013

A new type of defibrillator implanted under the skin can detect dangerously abnormal heart rhythms and deliver shocks to restore a normal heartbeat without wires touching the heart, according to research in the American Heart ...

Recommended for you

Macrophages shown to be essential to a healthy heart rhythm

April 20, 2017

A Massachusetts General Hospital (MGH)-led research team has identified a surprising new role for macrophages, the white blood cells primarily known for removing pathogens, cellular debris and other unwanted materials. In ...

3-D-printed patch can help mend a 'broken' heart

April 14, 2017

A team of biomedical engineering researchers, led by the University of Minnesota, has created a revolutionary 3D-bioprinted patch that can help heal scarred heart tissue after a heart attack. The discovery is a major step ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.